American Heart Association In Brief: CardioGenesis
This article was originally published in The Gray Sheet
Executive Summary
CardioGenesis: First human procedure with firm's PMR (percutaneous myocardial revascularization) system is completed at Herzzentrum (Heart Center) Frankfurt AG in Frankfurt, Germany. CardioGenesis' system is designed for use by interventional cardiologists as a minimally invasive method for transmyocardial revascularization ("The Gray Sheet" Aug. 19, I&W-2). The company, which initially is conducting clinical trials overseas, plans to submit an investigational device exemption to FDA in the first half of 1997...